{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:32:23Z","timestamp":1755797543411,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jiac.2025.102782","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:08:34Z","timestamp":1754492914000},"page":"102782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disseminated gonococcal infection developing two days after initial eculizumab administration in a patient with neuromyelitis optica spectrum disorder: A case report and literature review"],"prefix":"10.1016","volume":"31","author":[{"given":"Yusuke","family":"Nishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0192-163X","authenticated-orcid":false,"given":"Daisuke","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0450-6773","authenticated-orcid":false,"given":"Kazuyuki","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikoaki","family":"Fukaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiyu","family":"Ebata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachie","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9883-6986","authenticated-orcid":false,"given":"Yasuhiro","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102782_bib1","first-page":"853","article-title":"Gonococcal arthritis (disseminated gonococcal infection)","volume":"19","author":"Rice","year":"2005","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.jiac.2025.102782_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0889-857X(05)70011-9","article-title":"Gonococcal arthritis","volume":"24","author":"Cucurull","year":"1998","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.jiac.2025.102782_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1521-6942(02)00125-0","article-title":"Gonococcal arthritis","volume":"17","author":"Bardin","year":"2003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jiac.2025.102782_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2025.102782_bib5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CMR.00048-09","article-title":"Infections of people with complement deficiencies and patients who have undergone splenectomy","volume":"23","author":"Ram","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2025.102782_bib6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in Aquaporin-4\u2013Positive neuromyelitis Optica Spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102782_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jiac.2025.102782_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105829","article-title":"Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan","volume":"90","author":"Niino","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jiac.2025.102782_bib10","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1002\/1873-3468.13760","article-title":"Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms","volume":"594","author":"Lewis","year":"2020","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jiac.2025.102782_bib11","article-title":"Eculizumab's unintentional mayhem: a systematic review","volume":"14","author":"Dhanoa","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jiac.2025.102782_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/INF.0b013e3182503849","article-title":"Gonococcal septic shock associated with eculizumab treatment","volume":"31","author":"Gleesing","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2025.102782_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/OLQ.0000000000000202","article-title":"Disseminated gonococcal infection and eculizumab-A \u201chigh risk\u201d connection?","volume":"41","author":"Hublikar","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jiac.2025.102782_bib14","doi-asserted-by":"crossref","first-page":"E1558","DOI":"10.1503\/cmaj.170508","article-title":"Risks of novel therapeutics: gonococcemia in an immune-suppressed patient receiving eculizumab","volume":"189","author":"Khandelwal","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.jiac.2025.102782_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/IJGM.S255298","article-title":"Disseminated gonococcal infection associated with eculizumab therapy for paroxysmal nocturnal hemoglobinuria: a case report and literature review","volume":"13","author":"Saito","year":"2020","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jiac.2025.102782_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1473-3099(20)30930-0","article-title":"Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab","volume":"21","author":"Niitsuma-Sugaya","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2025.102782_bib17","first-page":"1","article-title":"Diffuse Gonococcal Infection (DGI) in a patient with treatment-refractory acetylcholine receptor antibody-positive (AChR+) generalized Myasthenia Gravis (gMG) treated with eculizumab","author":"Katyal","year":"20212021","journal-title":"Case Rep Neurol Med"},{"key":"10.1016\/j.jiac.2025.102782_bib18","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1097\/MPH.0000000000002075","article-title":"Risk of disseminated gonococcal infections with terminal complement blockade","volume":"44","author":"Graciaa","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jiac.2025.102782_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000543216","article-title":"Safety and effectiveness of eculizumab throughout three pregnancies in a patient with refractory generalized Myasthenia Gravis: a case report","author":"Khalil","year":"2025","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.jiac.2025.102782_bib20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/cid\/ciy958","article-title":"Disseminated gonococcal infections in patients receiving eculizumab: a case series","volume":"69","author":"Crew","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jiac.2025.102782_bib21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/ana.26049","article-title":"PREVENT Study group. Long-term safety and efficacy of eculizumab in aquaporin-4 IgG-positive NMOSD","volume":"89","author":"Wingerchuk","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jiac.2025.102782_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood-2014-03-560540","article-title":"Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab","volume":"125","author":"Peffault de Latour","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2025.102782_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0128-6","article-title":"Gonorrhoea","volume":"5","author":"Unemo","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jiac.2025.102782_bib24","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine","volume":"66","author":"McNamara","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2025.102782_bib25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jiac.2023.08.003","article-title":"The third nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2016-2017","volume":"29","author":"Yasuda","year":"2023","journal-title":"J Infect Chemother"},{"year":"2015","series-title":"M07-A10: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","key":"10.1016\/j.jiac.2025.102782_bib26"},{"key":"10.1016\/j.jiac.2025.102782_bib27","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/cid\/ciac043","article-title":"Management of Neisseria gonorrhoeae in the United States: summary of evidence from the development of the 2020 gonorrhea treatment recommendations and the 2021 centers for disease control and prevention sexually transmitted infection treatment guidelines","volume":"74","author":"Barbee","year":"2022","journal-title":"Clin Infect Dis"},{"year":"2025","series-title":"CLSI Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI Document m100","key":"10.1016\/j.jiac.2025.102782_bib28"},{"key":"10.1016\/j.jiac.2025.102782_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1099\/jmm.0.000651","article-title":"Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment","volume":"67","author":"Papp","year":"2018","journal-title":"J Med Microbiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:12:44Z","timestamp":1755551564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1341321X25001795"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102782","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disseminated gonococcal infection developing two days after initial eculizumab administration in a patient with neuromyelitis optica spectrum disorder: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102782"}}